The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Developing a new resource for drug discovery: marine actinomycete bacteria
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phylogenetic identification and in situ detection of individual microbial cells without cultivation
Amann, R., Ludwig, W., & SCHLEIFER, K. H. (1995) · Microbiological Reviews · doi:10.1128/mmbr.59.1.143-169.1995 · Cited by 9,093
Environmental genome shotgun sequencing of the sargasso sea
Venter, J. C., Remington, K., Heidelberg, J. F., Halpern, A. L., Rusch, D., Eisen, J. A., Wu, D., Paulsen, I., Nelson, K. E., Nelson, W., et al. (2004) · Science · doi:10.1126/science.1093857 · Cited by 4,376
Bioactive Microbial Metabolites: A Personal View
Bérdy, J. (2005) · The Journal of Antibiotics · doi:10.1038/ja.2005.1 · Cited by 3,170
Natural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082
The crisis in antibiotic resistance
Neu, H. C. (1992) · Science · doi:10.1126/science.257.5073.1064 · Cited by 2,834 · cited 1×
“Given the urgent need for new antibiotics to stem the tide of drug-resistant pathogen”
BackgroundThe evolving role of natural products in drug discovery
Koehn, F. E., & Carter, G. T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1657 · Cited by 2,572
Lessons from natural molecules
Clardy, J., & Walsh, C. (2004) · Nature · doi:10.1038/nature03194 · Cited by 1,171
Feling, R. H., Buchanan, G. O., Mincer, T. J., Kauffman, C. A., Jensen, P. R., & Fenical, W. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200390115 · Cited by 1,057
Self-citationMarine Natural Products and Related Compounds in Clinical and Advanced Preclinical Trials
Newman, D. J., & Cragg, G. M. (2004) · Journal of Natural Products · doi:10.1021/np040031y · Cited by 759
Where will new antibiotics come from?
Walsh, C. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro727 · Cited by 755
Cited by
Natural products in drug discovery
Harvey, A. L. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.07.004 · Cited by 1,832
Clinical relevance of the ESKAPE pathogens
Pendleton, J. N., Gorman, S. P., & Gilmore, B. F. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.13.12 · Cited by 1,423
Genomic basis for natural product biosynthetic diversity in the actinomycetes
Nett, M., Ikeda, H., & Moore, B. S. (2009) · Natural Product Reports · doi:10.1039/b817069j · Cited by 757
Gerwick, W. H., & Moore, B. S. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.12.014 · Cited by 601
Metabolites from symbiotic bacteria
Piel, J. (2009) · Nat. Prod. Rep. · doi:10.1039/b703499g · Cited by 577
Udwary, D. W., Zeigler, L., Asolkar, R. N., Singan, V., Lapidus, A., Fenical, W., Jensen, P. R., & Moore, B. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700962104 · Cited by 536
Self-citationGomez‐Escribano, J. P., & Bibb, M. J. (2011) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2010.00219.x · Cited by 534
New aspects of natural products in drug discovery
Lam, K. S. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2007.04.001 · Cited by 531
Modern Natural Products Drug Discovery and Its Relevance to Biodiversity Conservation
Kingston, D. G. I. (2011) · Journal of Natural Products · doi:10.1021/np100550t · Cited by 516
Renaissance in antibacterial discovery from actinomycetes
BALTZ, R. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.04.008 · Cited by 498
Blunt, J. W., Copp, B. R., Keyzers, R. A., Munro, M. H. G., & Prinsep, M. R. (2012) · Nat. Prod. Rep. · doi:10.1039/c2np00090c · Cited by 482
Mayer, A. M. S., Rodríguez, A. D., Berlinck, R. G. S., & Hamann, M. T. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.03.011 · Cited by 458
Marine actinomycetes: An ongoing source of novel bioactive metabolites
Subramani, R., & Aalbersberg, W. (2012) · Microbiological Research · doi:10.1016/j.micres.2012.06.005 · Cited by 453
Marine Natural Products: A New Wave of Drugs?
Montaser, R., & Luesch, H. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.118 · Cited by 437
Taori, K., Paul, V. J., & Luesch, H. (2008) · Journal of the American Chemical Society · doi:10.1021/ja7110064 · Cited by 428
Pharmaceutically active secondary metabolites of marine actinobacteria
Manivasagan, P., Venkatesan, J., Sivakumar, K., & Kim, S.-K. (2014) · Microbiological Research · doi:10.1016/j.micres.2013.07.014 · Cited by 416
Marine actinobacteria: new opportunities for natural product search and discovery
Bull, A. T., & Stach, J. E. M. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2007.10.004 · Cited by 391
Actinomycetes for marine drug discovery isolated from mangrove soils and plants in China
Hong, K., Gao, A.-H., Xie, Q.-Y., Gao, H. G., Zhuang, L., Lin, H.-P., Yu, H.-P., Li, J., Yao, X.-S., Goodfellow, M., et al. (2009) · Marine Drugs · doi:10.3390/md7010024 · Cited by 372
Blunt, J. W., Copp, B. R., Hu, W.-P., Munro, M. H. G., Northcote, P. T., & Prinsep, M. R. (2008) · Natural Product Reports · doi:10.1039/b701534h · Cited by 365
The use of secondary metabolite profiling in chemotaxonomy of filamentous fungi
Frisvad, J. C., Andersen, B., & Thrane, U. (2008) · Mycological Research · doi:10.1016/j.mycres.2007.08.018 · Cited by 363
A guide to successful bioprospecting: informed by actinobacterial systematics
Goodfellow, M., & Fiedler, H.-P. (2010) · Antonie van Leeuwenhoek · doi:10.1007/s10482-010-9460-2 · Cited by 356
Two interconverting Fe(IV) intermediates in aliphatic chlorination by the halogenase CytC3
Galonić, D. P., Barr, E. W., Walsh, C. T., Bollinger, J. M., & Krebs, C. (2007) · Nature Chemical Biology · doi:10.1038/nchembio856 · Cited by 350
Bio-mining the microbial treasures of the ocean: New natural products
Imhoff, J. F., Labes, A., & Wiese, J. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.03.001 · Cited by 346
Antitumor compounds from marine actinomycetes
Olano, C., Méndez, C., & Salas, J. A. (2009) · Marine Drugs · doi:10.3390/md7020210 · Cited by 330
“In addition, in the last years the isolation of marine actinomycetes has been a great source of new compounds and their isolation all around the globe, from shallow costal sediments to the deepest sediments from the Mariana Trench, demonstrates that actinomycetes are ubiquitous in marine sediments, but at lower number…”
BackgroundThe Marinopyrroles, Antibiotics of an Unprecedented Structure Class from a Marine Streptomyces sp.
Hughes, C. C., Prieto-Davo, A., Jensen, P. R., & Fenical, W. (2008) · Organic Letters · doi:10.1021/ol702952n · Cited by 311
Self-citationNesme, J., & Simonet, P. (2015) · Environmental Microbiology · doi:10.1111/1462-2920.12631 · Cited by 303
Rare actinomycetes: a potential storehouse for novel antibiotics
Tiwari, K., & Gupta, R. K. (2012) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2011.562482 · Cited by 297
Phylogenetic Framework and Molecular Signatures for the Main Clades of the Phylum Actinobacteria
Gao, B., & Gupta, R. S. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05011-11 · Cited by 281
Diversity and evolution of secondary metabolism in the marine actinomycete genus Salinispora
Ziemert, N., Lechner, A., Wietz, M., Millán-Aguiñaga, N., Chavarria, K. L., & Jensen, P. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1324161111 · Cited by 278
Self-citationSubramani, R., & Sipkema, D. (2019) · Marine Drugs · doi:10.3390/md17050249 · Cited by 271
Clustered patterns of species origins of nature-derived drugs and clues for future bioprospecting
Zhu, F., Qin, C., Tao, L., Liu, X., Shi, Z., Ma, X., Jia, J., Tan, Y., Cui, C., Lin, J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107336108 · Cited by 255
Photoprotective compounds from marine organisms
Rastogi, R. P., Richa, Sinha, R. P., Singh, S. P., & Häder, D.-P. (2010) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-010-0718-5 · Cited by 232
Valliappan, K., Sun, W., & Li, Z. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-5954-6 · Cited by 111
Alvarez-Mico, X., Jensen, P. R., Fenical, W., & Hughes, C. C. (2013) · Organic Letters · doi:10.1021/ol303374e · Cited by 69
Self-citationMicrobial synthesis and transformation of inorganic and organic chlorine compounds
Atashgahi, S., Liebensteiner, M. G., Janssen, D. B., Smidt, H., Stams, A. J. M., & Sipkema, D. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03079 · Cited by 64
Bose, U., Hewavitharana, A., Ng, Y., Shaw, P., Fuerst, J., & Hodson, M. (2015) · Marine Drugs · doi:10.3390/md13010249 · Cited by 64
Antioxidant marine products in cancer chemoprevention
Park, E.-J., & Pezzuto, J. M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5235 · Cited by 49
“Metabolites from actinomycete bacteria (soil-derived genera Streptomyces and Micromonospora ) consist of more than 50% of microbial anti-biotics (30).”
Metadata
- Authors
- Fenical, W., & Jensen, P. R.
- Venue
- Nature Chemical Biology
- Published
- 2006-12
- Volume
- 2
- Issue
- 12
- Pages
- 666-673
- ISSN
- 1552-4450 (ISSN-L)
- OpenAlex
- W2078415854
- Cited by
- 786
- References
- 47
- FWCI
- 18.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.